RecruitingPhase 1NCT06366789
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Lomond Therapeutics Holdings, Inc.
College Park, MD · +11 more sites